Sabra Healthcare REIT, Inc.

SBRA Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.

Revenue
+31.3%
EPS
+24.1%
Free cash flow
+26.7%
Total debt
−5.99%

Quarter to September 2026, against a year earlier

21.05 0.16 +0.77%
Market cap
$5.5B
P/E
74.7×
Fwd P/E
48.8×
Dividend yield
5.70%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Sabra Healthcare REIT, Inc. (SBRA) EV/EBITDA

Alert me on EV/EBITDA

As of 6 November 2026, Sabra Healthcare REIT, Inc. (SBRA) trades at a EV/EBITDA of 20.0×. Over the past ten years it has ranged from 8.5× (April 2020) to 24.9× (October 2017); the current reading is higher than 96% of that period. That is above the Reit Healthcare Facilities industry median of 17.6× and above the Real Estate sector median of 15.3×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 15.8× 1.03%
FY2024 15.7× 8.26%
FY2023 14.5× (11.40%)
FY2022 16.3× 18.43%
FY2021 13.8× 0.34%
FY2020 13.7× (13.52%)
FY2019 15.9× 29.09%
FY2018 12.3× (21.03%)
FY2017 15.6× 12.38%
FY2016 13.9× 6.03%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 19.1× (4.36%)
Jun 2026 20.0× 22.50%
Mar 2026 16.3× 2.94%
Dec 2025 15.8× 1.10%
43 more quarters

Against its own ten years

Low 8.5× High 24.9×
Ten-year median 15.1×
Current reading's percentile 96

EV/EBITDA against peers

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SBRA